About us

About us

For pharma and biotech companies, managing the clinical research process effectively is key to gaining competitive advantage and bringing treatments to patients in need. As the operational costs of clinical trials continue to expand, and government and regulatory regulations become increasingly stringent, effective management of clinical trial data helps to streamline the complexities of clinical trials and is critical to advancing the cycle of development.

At Business & Decision Life Sciences, we are experts in handling and managing clinical trial data, with the goal of helping our customers maximize the clinical trial process and bring their products to the market faster and more efficiently. With in-depth expertise in data standards and biometrics, we combine both for a wider perspective, eliminating silos and creating new approaches that help our customers reach their objectives.

With over 25 years of expertise in the management of clinical trial data, we like to say that data is in our DNA. We offer flexible, tailored data management solutions that align with our customers’ needs, enabling powerful operational and analytical advantages.

Business & Decision Life Sciences,<br>Data experts since 1992

Business & Decision Life Sciences,
Data experts since 1992

  • € 210 m 2020 Group Revenue
  • 11 Countries in the world
  • 2400 Employees

25 years of history!

  • 1992

    Business & Decision was founded by Patrick Bensabat

  • 2001

    FLUX Consulting (Belgium) is acquired by Business&Decision Group

  • 2007

    BUSINESS & DECISION LIFE SCIENCES IS FOUNDED

  • 2014

    Uchrony is aquired, now our Web & Mobile Division

  • 2017

    Agreement with Orange Group to acquire shares of majority shareholders

  • 2018

    Business & Decision Life Sciences is a subsidiary of Orange group

Our Values

Business & Decision was founded with the ambition to create a human-centric, agile, Innovative and collaborative organisation, giving place to individual initiative and creativity, and putting accent on RESPECT, EXCELLENCE and HUMILITY, which are the core values of B&D group.

This ambition is a necessary condition to create an agile, adaptable and performant organisation, where every person is concerned to create added value to our clients. Our pride is to be a diversity-rich and tolerant organisation, taking advantage of people’s strengths, and collaboratively mitigate the weak points.

Our professional life should be exciting and pleasant, and B&D people are passionate about their work, so we add “FUN” to core values of the organisation.

Life Sciences Management

  • CEO Business & Decision Life Sciences group
    Yoann Cotte
  • Country Manager Belgium
    Benoit Thomas
  • Director Cross-functional Projects and eHealth
    Claire Blondel
  • Regional Marketing Director
    Gerrit Denayer
  • HR Director
    Steven op 't Roodt
  • Chief Financial Officer
    Emmanuel Steels